229 related articles for article (PubMed ID: 35544594)
21. S100A8/A9 is an important host defence mediator in neuropathic foot ulcers in patients with type 2 diabetes mellitus.
Trøstrup H; Holstein P; Christophersen L; Jørgensen B; Karlsmark T; Høiby N; Moser C; Ågren MS
Arch Dermatol Res; 2016 Jul; 308(5):347-55. PubMed ID: 27084691
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-21-3p accelerates diabetic wound healing in mice by downregulating SPRY1.
Wu Y; Zhang K; Liu R; Zhang H; Chen D; Yu S; Chen W; Wan S; Zhang Y; Jia Z; Chen R; Ding F
Aging (Albany NY); 2020 Jul; 12(15):15436-15445. PubMed ID: 32634115
[TBL] [Abstract][Full Text] [Related]
23. A gene chip study suggests that miR-17-3p is associated with diabetic foot ulcers.
Sun XJ; Chen JA; Wang L; Li G; Wang AP
Int Wound J; 2023 May; 20(5):1525-1533. PubMed ID: 36333728
[TBL] [Abstract][Full Text] [Related]
24. Staphylococcus aureus Triggers Induction of miR-15B-5P to Diminish DNA Repair and Deregulate Inflammatory Response in Diabetic Foot Ulcers.
Ramirez HA; Pastar I; Jozic I; Stojadinovic O; Stone RC; Ojeh N; Gil J; Davis SC; Kirsner RS; Tomic-Canic M
J Invest Dermatol; 2018 May; 138(5):1187-1196. PubMed ID: 29273315
[TBL] [Abstract][Full Text] [Related]
25. MiR equal than others: MicroRNA enhancement for cutaneous wound healing.
Ross K
J Cell Physiol; 2021 Dec; 236(12):8050-8059. PubMed ID: 34160067
[TBL] [Abstract][Full Text] [Related]
26. The role of surgical debridement in healing of diabetic foot ulcers.
Gordon KA; Lebrun EA; Tomic-Canic M; Kirsner RS
Skinmed; 2012; 10(1):24-6. PubMed ID: 22324173
[TBL] [Abstract][Full Text] [Related]
27. Intracellular Staphylococcus aureus triggers pyroptosis and contributes to inhibition of healing due to perforin-2 suppression.
Pastar I; Sawaya AP; Marjanovic J; Burgess JL; Strbo N; Rivas KE; Wikramanayake TC; Head CR; Stone RC; Jozic I; Stojadinovic O; Kornfeld EY; Kirsner RS; Lev-Tov H; Tomic-Canic M
J Clin Invest; 2021 Dec; 131(24):. PubMed ID: 34730110
[TBL] [Abstract][Full Text] [Related]
28. Ginsenoside (Rg-1) promoted the wound closure of diabetic foot ulcer through iNOS elevation via miR-23a/IRF-1 axis.
Cai HA; Huang L; Zheng LJ; Fu K; Wang J; Hu FD; Liao RY
Life Sci; 2019 Sep; 233():116525. PubMed ID: 31158376
[TBL] [Abstract][Full Text] [Related]
29. Exosomal IRF1-loaded rat adipose-derived stem cell sheet contributes to wound healing in the diabetic foot ulcers.
Wu M; Tu J; Huang J; Wen H; Zeng Y; Lu Y
Mol Med; 2023 Apr; 29(1):60. PubMed ID: 37098476
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of diabetic foot ulceration: A review.
Deng H; Li B; Shen Q; Zhang C; Kuang L; Chen R; Wang S; Ma Z; Li G
J Diabetes; 2023 Apr; 15(4):299-312. PubMed ID: 36891783
[TBL] [Abstract][Full Text] [Related]
31. Role of matrix metalloproteinases in diabetic foot ulcers: Potential therapeutic targets.
Fu K; Zheng X; Chen Y; Wu L; Yang Z; Chen X; Song W
Front Pharmacol; 2022; 13():1050630. PubMed ID: 36339630
[TBL] [Abstract][Full Text] [Related]
32. Topical Erythropoietin Accelerates Wound Closure in Patients with Diabetic Foot Ulcers: A Prospective, Multicenter, Single-Blind, Randomized, Controlled Trial.
Hamed S; Ullmann Y; Belokopytov M; Shoufani A; Kabha H; Masri S; Feldbrin Z; Kogan L; Kruchevsky D; Najjar R; Liu PY; Kerihuel JC; Akita S; Teot L
Rejuvenation Res; 2021 Aug; 24(4):251-261. PubMed ID: 33504262
[TBL] [Abstract][Full Text] [Related]
33. Role of fibroblast plasticity and heterogeneity in modulating angiogenesis and healing in the diabetic foot ulcer.
Rai V; Moellmer R; Agrawal DK
Mol Biol Rep; 2023 Feb; 50(2):1913-1929. PubMed ID: 36528662
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of fluorescence biomodulation in the real-life management of chronic wounds: the EUREKA trial.
Romanelli M; Piaggesi A; Scapagnini G; Dini V; Janowska A; Iacopi E; Scarpa C; Fauverghe S; Bassetto F;
J Wound Care; 2018 Nov; 27(11):744-753. PubMed ID: 30398941
[TBL] [Abstract][Full Text] [Related]
35. Outcomes Following Advanced Wound Care for Diabetic Foot Ulcers: A Canadian Study.
Roth-Albin I; Mai SHC; Ahmed Z; Cheng J; Choong K; Mayer PV
Can J Diabetes; 2017 Feb; 41(1):26-32. PubMed ID: 27634016
[TBL] [Abstract][Full Text] [Related]
36. Decreased expression of miR-204-3p in peripheral blood and wound margin tissue associated with the onset and poor wound healing of diabetic foot ulcers.
Zhao X; Xu M; Tang Y; Xie D; Deng L; Chen M; Wang Y
Int Wound J; 2023 Feb; 20(2):413-429. PubMed ID: 35879811
[TBL] [Abstract][Full Text] [Related]
37. Expression of apoptosis- and cell cycle-related proteins in epidermis of venous leg and diabetic foot ulcers.
Galkowska H; Olszewsk WL; Wojewodzka U; Mijal J; Filipiuk E
Surgery; 2003 Aug; 134(2):213-20. PubMed ID: 12947320
[TBL] [Abstract][Full Text] [Related]
38. Beta-adrenergic antagonist for the healing of chronic diabetic foot ulcers: study protocol for a prospective, randomized, double-blinded, controlled and parallel-group study.
Kaur R; Tchanque-Fossuo C; West K; Hadian Y; Gallegos A; Yoon D; Ismailyan L; Schaefer S; Dahle SE; Isseroff RR
Trials; 2020 Jun; 21(1):496. PubMed ID: 32513257
[TBL] [Abstract][Full Text] [Related]
39. Negative pressure wound therapy, artificial skin and autogenous skin implantation in diabetic foot ulcers.
Chia-Jui H; Yu L; Jiang YQ; Tan W; Gao GM; Li HB; Han L
J Wound Care; 2022 Jan; 31(1):40-46. PubMed ID: 35077212
[TBL] [Abstract][Full Text] [Related]
40. Management of chronic diabetic foot ulcers using platelet-rich plasma.
Babaei V; Afradi H; Gohardani HZ; Nasseri F; Azarafza M; Teimourian S
J Wound Care; 2017 Dec; 26(12):784-787. PubMed ID: 29244965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
